Literature DB >> 2313049

Cognitive deterioration in Alzheimer's disease: behavioral and health factors.

L Teri1, J P Hughes, E B Larson.   

Abstract

Alzheimer's disease is characterized by progressive cognitive decline. However, little is known about the "typical" rate of decline, the degree of individual heterogeneity evident in decline, or the types of factors that influence such decline. This study investigated these questions in a sample of 106 patients with Alzheimer's disease, assessed at 1-5 points in time, spanning up to three years. At each time point, the Mini-Mental State Exam, a measure of global cognitive function, was administered to all patients. Measures of behavioral disturbance (including the presence/absence of hallucinations, depression, incontinence, wandering, and agitation), health status (including presence/absence of neurological, cardiovascular, and other diseases), and descriptive information (such as gender, age at time of onset, and duration of deficits) were obtained at entry into the study. A two-stage random effects regression model was fit to the data and then used to assess the effect of these behavioral, health, and descriptive measures on the rate of decline. Results indicate that the rate of cognitive decline in Alzheimer's disease is quite variable. Patients with various health and behavioral problems declined at a rate between 1.4 and 5 times faster than patients without such problems. Alcohol abuse, additional neurological disease, and agitation were significantly related to rate of decline. Overall number of problems was not. The association of these problems with accelerated decline may have prognostic and treatment implications.

Entities:  

Mesh:

Year:  1990        PMID: 2313049     DOI: 10.1093/geronj/45.2.p58

Source DB:  PubMed          Journal:  J Gerontol        ISSN: 0022-1422


  6 in total

1.  Alpha rhythm oscillations and MMSE scores are differently modified by transdermal or oral rivastigmine in patients with Alzheimer's disease.

Authors:  Davide V Moretti
Journal:  Am J Neurodegener Dis       Date:  2014-09-06

2.  Delusions and hallucinations are associated with worse outcome in Alzheimer disease.

Authors:  Nikolaos Scarmeas; Jason Brandt; Marilyn Albert; Georgios Hadjigeorgiou; Alexandros Papadimitriou; Bruno Dubois; Maria Sarazin; Davangere Devanand; Lawrence Honig; Karen Marder; Karen Bell; Domonick Wegesin; Deborah Blacker; Yaakov Stern
Journal:  Arch Neurol       Date:  2005-10

Review 3.  Modeling the time-course of Alzheimer dementia.

Authors:  J W Ashford; F A Schmitt
Journal:  Curr Psychiatry Rep       Date:  2001-02       Impact factor: 5.285

4.  Disruptive behavior as a predictor in Alzheimer disease.

Authors:  Nikolaos Scarmeas; Jason Brandt; Deborah Blacker; Marilyn Albert; Georgios Hadjigeorgiou; Bruno Dubois; Davangere Devanand; Lawrence Honig; Yaakov Stern
Journal:  Arch Neurol       Date:  2007-12

5.  The effect of diagnosing Alzheimer's disease on frequency of physician visits: a case-control study.

Authors:  W C McCormick; W A Kukull; G van Belle; J D Bowen; L Teri; E B Larson
Journal:  J Gen Intern Med       Date:  1995-04       Impact factor: 5.128

6.  The Pathology of Rapid Cognitive Decline in Clinically Diagnosed Alzheimer's Disease.

Authors:  Christin Nance; Aaron Ritter; Justin B Miller; Brittany Lapin; Sarah J Banks
Journal:  J Alzheimers Dis       Date:  2019       Impact factor: 4.472

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.